| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-16 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-13 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-13 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-12 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-09 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |